Adenosine triphosphate promotes locomotor recovery after spinal cord injury by activating mammalian target of rapamycin pathway in rats

Neural Regeneration Research

Volumn 8, Issue 2, 2013, Pages 101-110

  Sun, Zhen Gang ^a,b   Hu, Ling Yun ^b,c   Wen, Yi Min ^b,d   Chen, Ke Ming ^d   Sun, Zhen Juan ^e   Yue, Hai Yuan ^b   Zhang, Chao ^b  

^a Department of Hemodialysis   (China)

^b LANZHOU UNIVERSITY   (China)

^c Nanchong Central Hospital   (China)

^d LANZHOU GENERAL HOSPITAL   (China)

^e Eighth People's Hospital of Qingdao City   (China)

Author keywords

Adenosine triphosphate; Mammalian target of rapamycin pathway; Neural regeneration; Neuroregeneration; Photographs containing paper; Rapamycin; Serine threonine specific protein kinase; Signal pathway; Signal transduction and activator of transcription 3; Spinal cord injury

Indexed keywords

ADENOSINE TRIPHOSPHATE; GLIAL FIBRILLARY ACIDIC PROTEIN; MAMMALIAN TARGET OF RAPAMYCIN; NESTIN; NEUROFILAMENT PROTEIN; NEURON SPECIFIC ENOLASE; PROTEIN KINASE B; RAPAMYCIN; STAT3 PROTEIN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTOSIS; BEHAVIOR; CONTROLLED STUDY; FEMALE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LOCOMOTION; NERVE FIBER GROWTH; NERVOUS SYSTEM DEVELOPMENT; NEURAL STEM CELL; NONHUMAN; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; SPINAL CORD INJURY; WESTERN BLOTTING;

EID: 84925684934     PISSN: 16735374     EISSN: 18767958     Source Type: Journal    
DOI: 10.3969/j.issn.1673-5374.2013.02.001     Document Type: Article

References (32)

1. Wang B, Xiao Z, Chen B et al. Nogo-66 promotes the differentiation of neural progenitors into astroglial lineage cells through mTOR-STAT3 pathway. PLoS One. 2008;3: e1856.
2. Sango K, Yanagisawa H, Komuta Y, et al. Neuroprotective properties of ciliary neurotrophic factor for cultured adult rat dorsal root ganglion neurons. Histochem Cell Biol. 2008; 130:669-679.
3. Hu LY, Sun ZG, Wen YM, et al. ATP-mediated protein kinase B Akt/mammalian target of rapamycin mTOR/p70 ribosomal S6 protein p70S6 kinase signaling pathway activation promotes improvement of locomotor function after spinal cord injury in rats. Neuroscience. 2010;169: 1046-1062.
4. Yu W, Chen Z, Zhang J, et al. Critical role of phosphoinositide 3-kinase cascade in adipogenesis of human mesenchymal stem cells. Mol Cell Biochem. 2008; 310:11-18.
5. Wullschleger S, Loewith R, Hall MN. TOR signaling in growth and metabolism. Cell. 2006;124:471-484.
6. Dominguez E, Mauborgne A, Mallet J, et al. SOCS3-mediated blockade of JAK/STAT3 signaling pathway reveals its major contribution to spinal cord neuroinflammation and mechanical allodynia after peripheral nerve injury. J Neurosci. 2010;30:5754-5766.
7. Yu Y, Ren W, Ren B. Expression of signal transducers and activator of transcription 3 (STAT3) determines differentiation of olfactory bulb cells. Mol Cell Biochem. 2009;320:101-108.
8. Cotrina ML, Nedergaard M. Physiological and pathological functions of P2X7 receptor in the spinal cord. Purinergic Signal. 2009;5:223-232.
9. Gerasimovskaya EV, Tucker DA, Weiser-Evans M, et al. Extracellular ATP-induced proliferation of adventitial fibroblasts requires phosphoinositide 3-kinase, Akt, mammalian target of rapamycin, and p70 S6 kinase signaling pathways. J Biol Chem. 2005;280:1838-1848.
10. Neary JT. Protein kinase signaling cascades in CNS trauma. IUBMB Life 2005;57:711-718.
11. Dalziel HH, Westfall DP. Receptors for adenine nucleotides and nucleosides: subclassification, distribution, and molecular characterization. Pharmacol Rev. 1994;46:449-466.
12. Andres RH, Ducray AD, Schlattner U, et al. Functions and effects of creatine in the central nervous system. Brain Res Bull. 2008;76:329-343.
13. Shin DH, Min HY, El-Naggar AK, et al. Akt/mTOR counteract the antitumor activities of cixutumumab, an anti-insulin-like growth factor I receptor monoclonal antibody. Mol Cancer Ther. 2011;10:2437-2448.
14. Dominguez E, Rivat C, Pommier B, et al. JAK/STAT3 pathway is activated in spinal cord microglia after peripheral nerve injury and contributes to neuropathic pain development in rat. J Neurochem. 2008;107:50-60.
15. Dunlop EA, Tee AR. Mammalian target of rapamycin complex 1: signalling inputs, substrates and feedback mechanisms. Cell Signal. 2009;21:827-835.
16. Miyazaki M, Esser KA. Cellular mechanisms regulating protein synthesis and skeletal muscle hypertrophy in animals. J Appl Physiol. 2009;106:1367-1373.
17. Swiech L, Perycz M, Malik A,et al. Role of mTOR in physiology and pathology of the nervous system. Biochim Biophys Acta. 2008;1784:116-132.
18. Sarbassov DD, Ali SM, Sengupta S, et al. Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. Mol Cell. 2006;22:159-168.
19. Guertin DA, Sabatini DM. Defining the role of mTOR in cancer. Cancer Cell. 2007;12:9-22.
20. Grider MH, Park D, Spencer DM, et al. Lipid raft-targeted Akt promotes axonal branching and growth cone expansion via mTOR and Rac1, respectively. J Neurosci Res. 2009;87: 3033-3042.
21. Memmott RM, Dennis PA. Akt-dependent and -independent mechanisms of mTOR regulation in cancer. Cell Signal. 2009;21:656-664.
22. Read DE, Gorman AM. Involvement of Akt in neurite outgrowth. Cell Mol Life Sci. 2009;66:2975-2984.
23. Narayanan SP, Flores AI, Wang F, et al. Akt signals through the mammalian target of rapamycin pathway to regulate CNS myelination. J Neurosci. 2009;29:6860-6870.
24. Fitch MT, Silver J. CNS injury, glial scars, and inflammation: Inhibitory extracellular matrices and regeneration failure. Exp Neurol. 2008;209:294-301.
25. Inoue K, Koizumi S, Tsuda M. The role of nucleotides in the neuron--glia communication responsible for the brain functions. J Neurochem. 2007;102:1447-1458.
26. Rubinsztein DC, Gestwicki JE, Murphy LO, et al. Potential therapeutic applications of autophagy. Nat Rev Drug Discov. 2007;6:304-312.
27. Qiao L, Wong BC. Targeting apoptosis as an approach for gastrointestinal cancer therapy. Drug Resist Updat. 2009; 12:55-64.
28. Williams A, Sarkar S, Cuddon P, et al. Novel targets for Huntington's disease in an mTOR-independent autophagy pathway. Nat Chem Biol. 2008;4:295-305.
29. Peng W, Cotrina ML, Han X, et al. Systemic administration of an antagonist of the ATP-sensitive receptor P2X7 improves recovery after spinal cord injury. Proc Natl Acad Sci U S A. 2009;106:12489-12493.
30. The Ministry of Science and Technology of the People's Republic of China. Guidance Suggestions for the Care and Use of Laboratory Animals. 2006-09-30.
31. Meikle L, Pollizzi K, Egnor A, et al. Response of a neuronal model of tuberous sclerosis to mammalian target of rapamycin (mTOR) inhibitors: effects on mTORC1 and Akt signaling lead to improved survival and function. J Neurosci. 2008;28:5422-5432.
32. Basso DM, Beattie MS, Bresnahan JC. A sensitive and reliable locomotor rating scale for open field testing in rats. J Neurotrauma. 1995;12:1-21.